At this time, scientists are just beginning to learn how a diagnosis of thalassemia may affect the risk of COVID-19, ...

Thalassemia continues to be a significant health challenge in India, but with advancements in healthcare, early diagnosis, ...

To model mitapivat's potential in thalassemia, I will use aggressive ... Agios after they sold their oncology business) for the treatment of malignant brain tumors. This is expected to increase ...

Children ages 12 and older with sickle cell are now eligible for a newly FDA-approved treatment through the MACC Fund Center ...

Conditions such as alpha thalassemia major, where the fetus cannot produce adequate ... with survival rates for affected ...

Prime Minister’s Youth Programme Chairman Rana Mashhood Ahmed Khan said on Monday that a vigorous awareness campaign was ...

For those with beta-0 thalassemia, their condition is usually more severe, while beta+ thalassemia tends to be milder. Treatment and Care The main goal of treatment is to reduce painful episodes and ...

Given all these factors, it seems reasonable to assume that Casgevy could grab at least a decent share, perhaps 20% of its ...

Thirty-eight participants had homozygous hemoglobin S (Hb SS) genotype, 11 had sickle hemoglobin C (hemoglobin S and ...

Nagpur: In a significant development, renowned paediatrician Dr Vinky Rughwani has been nominated to the National Medical ...

CRISPR Therapeutics' first therapy is called Casgevy. It treats sickle cell disease (SCD) and beta thalassemia, both rare inherited illnesses that affect the function of a person's red blood cells. It ...